Pharmaceutical compositions and uses for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/565 (2006.01)

Patent

CA 2334702

Androst-5-ene-3.beta.,17.beta.-diol is used to treat or reduce the likelihood of acquiring osteoporosis or menopausal symptoms, or other diseases affected by estrogen receptor activity, and for conditions which respond well to DHEA treatment, but where a higher ratio of estrogenic to androgenic effects is desired. Combination therapies are included, as are kits and pharmaceutical compositions for providing the active ingredients of claimed methods and combinations.

L'androst-5-ène-3 beta ,17 beta -diol est utilisé pour traiter l'ostéoporose ou les symptômes ménopausiques ou pour réduire les risques d'apparition de ces affections ou d'autres affections liées à une activité des récepteurs d'oestrogènes, et pour traiter des états qui réagissent bien à un traitement par déhydroépiandrostérone (DHEA), mais où un rapport élevé entre effets oestrogéniques et androgéniques est souhaité. Cette invention présente des thérapies combinées, ainsi que des trousses et des compositions pharmaceutiques fournissant les agents actifs des procédés et des combinaisons revendiqués dans cette invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions and uses for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and uses for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and uses for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1960554

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.